NDC 61874-115

Vraylar

Cariprazine

Vraylar is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Cariprazine.

• Product ID: 61874-115_03e4d2c4-600f-42a3-966e-254b83f38ccd
• NDC: 61874-115
• Product Type: Human Prescription Drug
• Proprietary Name: Vraylar
• Generic Name: Cariprazine
• Dosage Form: Capsule, Gelatin Coated
• Route of Administration: ORAL
• Marketing Start Date: 2015-09-17
• Marketing Category: NDA / NDA
• Application Number: NDA204370
• Labeler Name: Allergan, Inc.
• Substance Name: CARIPRAZINE
• Active Ingredient Strength: 2 mg/1
• Pharm Classes: Atypical Antipsychotic [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61874-115-07

7 CAPSULE, GELATIN COATED in 1 BLISTER PACK (61874-115-07)

• Marketing Start Date: 2016-03-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61874-115-17 [61874011517]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-03-01

NDC 61874-115-90 [61874011590]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-03-01
• Marketing End Date: 2019-05-24

NDC 61874-115-07 [61874011507]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-03-01

NDC 61874-115-30 [61874011530]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-03-01

NDC 61874-115-11 [61874011511]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2015-09-17

NDC 61874-115-31 [61874011531]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2016-03-01

NDC 61874-115-63 [61874011563]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2015-09-17
• Marketing End Date: 2016-11-28

NDC 61874-115-20 [61874011520]

Vraylar CAPSULE, GELATIN COATED

• Marketing Category: NDA
• Application Number: NDA204370
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-03-01

Drug Details

Active Ingredients

Ingredient	Strength
CARIPRAZINE	1.5 mg/1

OpenFDA Data

• SPL SET ID: 4b5f7c65-aa2d-452a-b3db-bc85c06ff12f
• Manufacturer:
  • Allergan, Inc.
• UNII:
  • F6RJL8B278
• RxNorm Concept Unique ID - RxCUI:
  • 1667674
  • 1667666
  • 1667676
  • 1667670
  • 1667672
  • 1667660
  • 1667678
  • 1667668
  • 1741747
  • 1741746
• UPC Code:
  • 0361874160307
  • 0304561140077
  • 0361874115307
  • 0361874145304

Pharmacological Class

• Atypical Antipsychotic [EPC]

Medicade Reported Pricing

61874011530 VRAYLAR 1.5 MG CAPSULE

Pricing Unit: EA | Drug Type:

61874011520 VRAYLAR 1.5 MG CAPSULE

Pricing Unit: EA | Drug Type:

61874011511 VRAYLAR 1.5 MG CAPSULE

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Vraylar" or generic name "Cariprazine"

NDC	Brand Name	Generic Name
61874-115	Vraylar	cariprazine
61874-130	Vraylar	cariprazine
61874-145	Vraylar	cariprazine
61874-160	Vraylar	cariprazine
61874-170	Vraylar	cariprazine
70518-3157	Vraylar	cariprazine